Lotte Duty Free and China Duty Free Group (CDFG) have failed in their bids to secure a spot at Incheon Airport. They were not able to secure a license to set up their outlets at the facility while Hotel Shilla and Shinsegae Duty Free still remained as candidates for main operation at the said airport in South Korea.
It was reported that as Lotte Duty Free lost in its bid to operate at the Incheon International Airport, three other local companies were considered and officially shortlisted in the bidding. China’s largest duty-free company, the CDFG, also submitted its bid but did not make it to the list of candidates.
The three companies are now competing for the 10-year deal that will give the winner a license to operate at the popular airport. The lucky firms that were shortlisted are Hotel Shilla, Hyundai Department Store Duty Free, and Shinsegae.
According to Korea Joongang Daily, the three candidates have submitted multiple bids for a space within the five areas allotted for duty-free stores operated by large companies. The spaces are for cosmetics, perfume, accessories, luxury goods, fashion, and more.
All the duty-free firms seeking space at the Incheon airport presented their proposals last week. The airport said at the initial screening process that it would consider those with business capacity making up 60% of the evaluation score. The submitted bidding price will form the remaining 40%.
It was mentioned that the next round of screenings has been set for April, and it will be conducted by the Korea Customs Service. The agency will also be the one that will decide on the bidders' spots.
Meanwhile, The Korea Herald reported that business insiders opined that Lotte Duty Free’s failure to be shortlisted in the bidding process could be partly due to the partial withdrawal of its business at the Incheon Airport. It withdrew some of its stores in 2018 and only operated DF 3 after its successful bid for a spot in 2015.


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 



